BioNTech Posts Significant $721 Million Loss in 2024 Amid Decline in COVID-19 Vaccine Demand
Berlin: German biotech firm BioNTech reported a loss of £665.3 million ($721 million) in 2024, as demand for its COVID-19 vaccines fell, according to the company’s financial results report on Monday. The company, which posted a £930.3 million profit i…